Myrobalan Therapeutics

About Myrobalan Therapeutics

Myrobalan Therapeutics is focused on harnessing the restorative potential of novel CNS (Central Nervous System) therapeutics. Their strategy addresses demyelination and neuroinflammation, key drivers of diseases like multiple sclerosis, Alzheimer's, ALS, and Parkinson's. They aim to develop first-in-class and best-in-class oral small molecule therapies with a wide therapeutic margin and high CNS distribution for favorable safety and efficacy, using biomarker-guided precision neurology to target appropriate patient populations.

Products & Services

CSF1R Inhibitor Program:A program targeting CSF1R to address neuroinflammation and demyelination in CNS diseases.

GPR17 Antagonist:A therapeutic candidate targeting GPR17, with preclinical data presented at ECTRIMS 2024.

TYK2 Inhibitor:A program focused on TYK2 for the treatment of CNS disorders.

MRO-002:A developmental therapy for multiple sclerosis, supported by a grant from the National Multiple Sclerosis Society.

Specialties

CNS Therapeutics Neuroinflammation Demyelination Precision Neurology Oral Small Molecule Therapies Brain-Penetrant Compounds

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 850000 MR: - FA: over $850,000 FAN: 850000	D: 2025-03-13 FD: 2025-03-13	1 investors
2	RT: Grant T: - FT: Grant	A: 400000 MR: - FA: 400,000 FAN: 400000	D: 2024-02-07 FD: 2024-02-07	1 investors
3	RT: Series A T: - FT: Series A	A: 24000000 MR: - FA: $24 million FAN: 24000000	D: 2024-01-10 FD: 2024-01-10	4 investors

Grant Latest

2025-03-13

$850K

1 investor (Pro only)

Grant 2024-02-07

$400K

Series A 2024-01-10

$24.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Z

Zhigang He

Scientific Co-Founder, Board Advisor

G

Guoping Feng

Scientific Co-Founder, Board Member

J

Jing Wang

Co-Founder & CEO, Board Member

R

Robin Kleiman

Chief Scientific Officer

J

Jaren Landen

Fractional Chief Medical Officer

E

Ed Wu

Head of Medicinal Chemistry

View 27 more team members with Pro

Unlock Full Team Directory

Recent News